Genetically Modified Therapeutic Autologous Lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically Modified Therapeutic Autologous Lymphocytes, covering 2024-10-08 to 2024-10-08. Get the full timeline:
Most recent: Clinical Trial Update: Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma [Phase 1, Phase 2]